Low Detection Rate of Multidrug-Resistant and Rifampicin-Resistant Tuberculosis in the Democratic Republic of Congo: Trend Analysis 2013-2017

Multidrug-Resistant Tuberculosis in the Democratic Republic of Congo: Analysis of Continuous Surveillance Data from 2007 to 2016

Implementing a Short Regimen for Multidrug-Resistant Tuberculosis in Kinshasa, Democratic Republic of Congo: A Cohort Study 2014-2017

Low-cost rapid detection of rifampicin resistant tuberculosis using bacteriophage in Kampala, Uganda

Abstract Background Resistance to anti-tuberculosis drugs is

Evolving rifampicin and isoniazid mono-resistance in a high multidrug-resistant and extensively drug-resistant tuberculosis region: a retrospective data analysis

Objectives South Africa ranks among the highest drug-re

PO 8408 DETECTION OF EXTENSIVELY DRUG-RESISTANT TUBERCULOSIS AMONG MULTIDRUG-RESISTANT <i>MYCOBACTERIUM TUBERCULOSIS</i> CLINICAL ISOLATES IN BOTSWANA

Background The emergence and transmission of multidrug-resistant (MDR) and exten

Multidrug resistant tuberculosis (MDR-TB) in Eritrea: a retrospective cohort analysis of mortality and associated factors (2013 – 2023)

Background Multi-drug resistant tuberculosis (MDR-TB) continues to be a pressi